2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow DSM265 400mg: new trials by email Literature Review of DSM265 400mg trials Research Report on DSM265 400mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax DSM265 400mg, DSM265 xmg, DSM265 ymg - Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria | Phase 2 | Completed | Medicines for Malaria Venture | 45 | 2016-01-01 | 2016-06-22 |
| DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria DSM265 400mg, Placebo to DSM265 400 mg, Plasmodium falciparum sporozoite challenge - Plasmodium Falciparum, Malaria | Phase 1 | Completed | Medicines for Malaria Venture | 22 | 2015-10-01 | 2021-01-13 |
Malaria (2) · Malaria, Falciparum (2) · Malaria, Vivax (1)
Medicines for Malaria Venture (2)
Germany (1) · Peru (1)
Alejandro Llanos, Professor (1)